Johnson & Johnson (JNJ) Tops Q1 EPS by 7c, Revenue Slightly Misses
Tweet
Share
E-mail
Get Alerts JNJ Hot Sheet
Price: $275.23 -1.15%
EPS Growth %: +3.6%
Financial Fact:
CASH DIVIDENDS PER SHARE: 0.8
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +3.6%
Financial Fact:
CASH DIVIDENDS PER SHARE: 0.8
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Johnson & Johnson (NYSE: JNJ) reported Q1 EPS of $2.71, $0.07 better than the analyst estimate of $2.64. Revenue for the quarter came in at $21.38 billion versus the consensus estimate of $21.4 billion.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- Goldman Sachs Downgrades Shurgard Self Storage SA (SHUR:BB) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
